Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey

Clinical Endocrinology

Volumn 49, Issue 1, 1998, Pages 21-28

  Weetman, A P ^a   Wiersinga, W M ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DECOMPRESSION SURGERY; EUROPE; EVOKED VISUAL RESPONSE; EYE DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE LESION; PRIORITY JOURNAL; SOCIAL ISOLATION; THYROID DISEASE; THYROIDECTOMY; TREATMENT PLANNING;

ANTITHYROID AGENTS; COMBINED MODALITY THERAPY; DECOMPRESSION, SURGICAL; DIABETES COMPLICATIONS; EUROPE; FEMALE; GLUCOCORTICOIDS; GRAVES DISEASE; HEALTH CARE SURVEYS; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; ORBIT; THYROIDECTOMY;

EID: 0031846326     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00487.x     Document Type: Article

References (22)

1. Bartalena, L., Marcocci, C., Bogazzi, F., Panicucci, M., Lepri, A. & Pinchera, A. (1989) Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism New England Journal of Medicine, 321, 1349-1352.
2. Bartalena, L., Marcocci, C., Bogazzi, F., Bruno-Bossi, G., Tanda, M.L., Vanni, G., Dell'Unto, E., Martino, E. & Pinchera, A. (1995) Further studies on the course of Graves' ophthalmopathy following radioactive iodine administration. Thyroid, 5 (Suppl. 1) S-70.
3. Bartley, G.B. (1994) The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Transactions of the American Ophthalmological Society, 92, 477-588.
4. Bartley, G.B. (1995) Evolution of classification systems for Graves' ophthalmopathy. Ophthalmic, Plastic and Reconstuctive Surgery, 11, 229-237.
5. Burch, H.B. & Wartofsky, L. (1993) Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocrine Reviews, 14, 747-793.
6. DeGroot, L.J., Gorman, C.A., Pinchera, A., Bartalena, L., Marcocci, C., Wiersinga, W.M., Prummel, M.F. & Wartofsky, L. (1995) Radiation and Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 80, 339-349.
7. European Thyroid Association, Japanese Thyroid Association, Asian-Oceania Thyroid Association, Latin-American Thyroid Association, American Thyroid Association (1992) Classification of Graves' disease. Thyroid. 2, 235-236.
8. Frueh, B.R. (1992) Why the NO SPECS classification of Graves' eye disease should be abandoned, with suggestions for the characterization of this disease. Thyroid, 2, 85-88.
9. Glinoer, D., Hesch, D., Lagasse, R. & Laurberg, P. (1987) The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey. Acta Endocrinologica, 115 (Suppl. 285), 1-23.
10. Gorman, C.A. (1991) Clever is not enough: NO SPECS is form in search of function. Thyroid, 1, 353-355.
11. Gorman, C.A. (1995) Radioiodine therapy does not aggravate Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 80, 340-342.
12. Mounts, M.P., Koornneef, L., Wiersinga, W.M., Prummel, M.F., Berghout, A. & van der Gaag, R. (1989) Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. British Journal of Ophthalmology, 73, 639-644.
13. Mourits, M.P., Koornneef, L., Wiersinga, W.M., Prummel, M.F., Berghout, A. & van der Gaag, R. (1990) Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology, 97, 636-641.
14. Nagayarna, Y., Izumi, M. & Nagataki, S. (1989) The management of hyperthyroidism due to Graves' disease in Japan in 1988. Endocrinologica Japonica, 36, 299-314.
15. Polak, B.C.P. & Wijngaarde, R. (1995) Radiation retinopathy in patients with both diabetes mellitus and ophthalmic Graves' disease. Orbit. 14, 71-74.
16. Prummel, M.F. & Wiersinga, W.M. (1993) Smoking and the risk of Graves' disease. Journal of the American Medical Association, 269, 479-482.
17. Shine, B., Fells, P., Edwards. O.M. & Weetman, A.P. (1990) Association between Graves' ophthalmopathy and smoking. Lancet, 335, 1261-1263.
18. Solomon, B., Glinoer, D., Lagasse, R. & Wartofsky, L. (1990) Current trends in the management of Graves' disease. Journal of Clinical Endocrinology and Metabolism, 70, 1518-1524.
19. Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.G., Blomgren, H., Taube, A. & the Thyroid Study Group. (1992) Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. New England Journal of Medicine, 326, 1733-1738.
20. Werner, S.C. (1977) Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. Journal of Clinical Endocrinology and Metabolism, 44, 203-204.
21. Wiersinga, W.M., Prummel, M.F., Mourits, M.P.H., Koornneef, L. & Buller, H.R. (1991) Classification of the eye changes of Graves' disease. Thyroid. 1, 357-360.
22. Winsa, B., Rastad, J., Åkerström, G., Johansson, H., Westermark, K. & Karlsson, F.A. (1995) Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy. European Journal of Endocrinology, 132, 406-412.